HUSSMAN STRATEGIC ADVISORS, INC.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1179475
ELLICOTT CITY, MD
Position in NBIX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,601,142
+$1,834,602 QoQ
Shares Held
27,300
+30.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#223
of 768 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HUSSMAN STRATEGIC ADVISORS, INC. holds $14,720,685 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (31.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
27,300 | $4,601,142 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
31,500 | $2,607,570 | |
| 3 | ALKS |
Alkermes plc.
|
42,000 | $2,200,800 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
210,000 | $2,100,000 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
42,000 | $1,318,800 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
2,100 | $1,137,843 | |
| 7 | ZTS |
Zoetis Inc.
|
10,500 | $754,530 |
All Filings in NBIX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,601,142 | 27,300 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,766,540 | 21,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,978,430 | 21,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,947,980 | 21,000 | Shares | Sole | 2025-11-03 | |
| 2025-03-31 | $2,787,120 | 25,200 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,146,600 | 8,400 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $3,629,430 | 31,500 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $3,469,284 | 25,200 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,448,160 | 10,500 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,383,480 | 10,500 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $3,195,000 | 28,400 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,432,520 | 36,400 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $4,706,730 | 46,500 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $3,105,440 | 26,000 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,313,752 | 31,200 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $3,041,376 | 31,200 | Shares | Sole | 2022-09-12 | |
| 2022-03-31 | $2,925,000 | 31,200 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $885,768 | 10,400 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,486,605 | 15,500 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $1,508,460 | 15,500 | Shares | Sole | 2021-08-03 | |
| 2020-09-30 | $961,600 | 10,000 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,220,000 | 10,000 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $1,298,250 | 15,000 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||